Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways - Wikidata - awgldk - TriplyDB

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

http://www.wikidata.org/entity/Q59066035

about

Reduction of atherosclerosis in mice by inhibition of CD40 signalling Immunological aspects of liver cell transplantation Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal Blockage Pluripotent stem cells: immune to the immune system?Biologics in organ transplantation Transplantation tolerance and its outcome during infections and inflammation Future prospects in immunosuppression for liver transplantation Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression A novel monoclonal antibody to CD40 prolongs islet allograft survival Definition of agonists and design of antagonists for alloreactive T cell clones using synthetic peptide libraries.Co-stimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig-to-baboon cardiac xenograft.Blockade of CD28 by a synthetical peptoid inhibits T-cell proliferation and attenuates graft-versus-host disease Pathogen Stimulation History Impacts Donor-Specific CD8(+) T Cell Susceptibility to Costimulation/Integrin Blockade-Based Therapy Transplantation tolerance: the concept and its applicability.Gene therapy in transplantation.The problem of anti-pig antibodies in pig-to-primate xenografting: current and novel methods of depletion and/or suppression of production of anti-pig antibodies.Transplantation tolerance-where do we stand?Blocking costimulatory signals to induce transplantation tolerance and prevent autoimmune disease.Antigen presentation by parenchymal cells: a route to peripheral tolerance?Tissue engineering: confronting the transplantation crisis.CD28, CTLA-4 and their ligands: who does what and to whom?CTLA4-Ig: a novel immunosuppressive agent.Promoting long-term survival of insulin-producing cell grafts that differentiate from adipose tissue-derived stem cells to cure type 1 diabetes New-generation recombinant factor concentrates: bridge to gene therapy.Current treatment practice in immunosuppression.Multiple costimulatory blockade in the peripheral nerve allograft.Immunosuppression without immunosuppression? How to be a tolerant individual in a dangerous world.Selective immunointervention in autoimmune diseases: lessons from multiple sclerosis.Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion.CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells.Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.A model of corrective gene transfer in X-linked ichthyosis.CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates Transient lymphopenia breaks costimulatory blockade-based peripheral tolerance and initiates cardiac allograft rejection Islet cell transplantation for the treatment of diabetes mellitus.Requirement for natural killer T (NKT) cells in the induction of allograft tolerance Nuclear calcium is required for human T cell activation.Multipotent mesenchymal stromal cells synergize with costimulation blockade in the inhibition of immune responses and the induction of Foxp3+ regulatory T cells.New approaches to immunosuppression in liver transplantation.Costimulation blockade inhibits the indirect pathway of allorecognition in nerve allograft rejection

P2860

Q24316540-2755F5D0-B7FE-4C1A-A061-3DD3F26A09C4 Q26751474-D9D45B90-63B9-4F18-8FD5-C6B3D1056F2B Q26778646-798F5789-874C-44A7-882A-DAEF375AEACF Q26823255-31868209-C904-45F5-B0B2-3445B284311C Q26829578-E1107729-9C6D-48A7-ABAD-303A3AE6188F Q26829817-29CEB236-19D7-4D0B-B0F2-938E56A3BD33 Q26860486-35431C5B-877E-4955-9162-056D2C1F2200 Q27022973-8BC624BE-0145-47F3-9110-B4A5107A49A7 Q30417821-F44B3D88-79AE-4AB3-BF76-BEBCC18CC986 Q30698407-4FC9C831-277C-4BC8-B5BA-4FB371AE614A Q33365683-693BCE3C-B5A1-479E-8E54-9B6F89C75F28 Q33530054-544B295A-B016-4751-8293-3EAC070D51E6 Q33636211-2D44146B-ACEA-425E-898E-96347FB93495 Q33732945-947CF882-7FC7-48DF-BF2E-532B5F7F8DCA Q33734501-21444C82-FF39-4FBB-8264-B8E9A1628CEB Q33742186-E88C0418-6505-453B-AFE1-AD50D8E2FFE4 Q33764678-AEDD4405-F01C-4E74-975B-ACE56D682174 Q33805849-FC06884E-0CC4-471D-B06B-F78F426F783D Q33815462-93AF2373-0291-4897-8C8C-CCA6A94FB087 Q33863367-B7BEBC1E-17F2-47BD-972C-10E040CD4242 Q34049974-6AAE9E07-F46D-4739-9070-9557915DCF8E Q34075083-D2DDA74B-019C-41F0-A45C-3D044F8D1059 Q34117889-B8158E58-15F7-4DA2-BF02-D533B0FFA348 Q34176033-0A179435-9007-4A43-8FCB-2E7AA3DE3924 Q34181796-A9C81C7D-B44C-414D-A527-0395D4B2E969 Q34246339-6A2B1386-F535-49AB-B180-4362C0BE9E78 Q34294802-319B7E0B-ECEE-4843-93CE-B76C0093B37A Q34307160-D6906744-F0EC-4FD6-8848-9E404A1E5D15 Q34322116-D19B700F-8E12-4ADE-B1A8-E377FF2395CC Q34336527-64CF8342-74AD-42F7-9A94-74AFF946C8E6 Q34412887-2FEEC5C2-F9CF-4517-9C3F-0F18BAD3161B Q34428074-1ADD02A1-B5BF-44D7-95D3-56E6C96E80CD Q34433847-917E21DD-5725-4A48-97E3-3254D4606BED Q34438306-70BAAA4A-897D-405B-9EA9-80905C301C99 Q34452096-2BB713F4-03B0-49C6-8C46-846B20B38B4B Q34475968-D826E65F-E22A-4A73-8DB4-7720CFAFE37B Q34544029-44D9DFB7-F03A-476F-B0FC-5D8BD02F37FE Q34601883-DF10CA77-48BE-4AB4-B916-7F2D10825689 Q34609660-B2FA9CCC-15FB-431B-8600-2887CCBE1F1A Q34675132-7337F257-D9C6-4BE6-BE7C-A6806DB233AF

P2860

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

http://www.wikidata.org/entity/Q59066035

description

article publié dans la revue scientifique Nature

@fr

наукова стаття, опублікована в травні 1996

@uk

name

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

@en

type

label

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

@en

prefLabel

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

@en

P1433

Q59066035-0E12F263-D4A5-4375-91FD-DAD020C03EED

P1476

Q59066035-C04AAF99-E36D-403C-BC80-12676EF1D7F9

P2093

Q59066035-14296E6E-AB79-4BD6-A22E-20704EE41BF9

Q59066035-1E86608F-F2E7-4A22-94B2-818B1EF8C250

Q59066035-29691A6E-E189-42B0-92C1-25B9D020A63E

Q59066035-4A9A3C11-346F-4A43-B107-06F529CA99BD

Q59066035-6C3548B7-4E8A-4CC0-B9BC-6B3C8E9BBDB8

Q59066035-8CC250B8-43F0-4E5B-8C04-139ADB9C89A8

Q59066035-91EFCD2C-4106-43AB-AA20-0FAE14F244AB

Q59066035-AB3DBFCC-12BF-434E-9861-1300534FE32B

Q59066035-AF8EDF95-A26D-4421-99DB-5A937657A22E

Q59066035-BD1AFEA7-0954-4EF9-A96E-29ADBB7548F5

P2888

Q59066035-3E95C55B-D2E9-4AFA-9C1E-5DFD16F0B052

P304

Q59066035-87880FBD-699D-4FD1-B3EE-2EFC7C3D8452

P31

Q59066035-CB0A65C6-8325-46B5-97E2-D514BDD9123E

P356

Q59066035-511B6B2E-DE09-4936-B6B2-C3249D91371E

P407

Q59066035-0C94E9EC-2700-4D82-BEF3-0AB5D89CC0D4

P433

Q59066035-A0BA0BEC-E6F9-4621-874E-B3235427951A

P478

Q59066035-3E1C6BF0-3667-4CA8-A6E5-935FC65D569D

P577

Q59066035-16E22693-1848-47B7-893A-9082C31C08BB

P6179

Q59066035-E4F7095E-0160-4BD1-80E6-6A66240A9AA2

P356

P1433

P1476

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

@en

P2093

Alejandro Aruffo

http://www.w3.org/2001/XMLSchema#string

Carol Tucker-Burden

http://www.w3.org/2001/XMLSchema#string

Christian P. Larsen

http://www.w3.org/2001/XMLSchema#string

Diane Hollenbaugh

http://www.w3.org/2001/XMLSchema#string

Diane Z. Alexander

http://www.w3.org/2001/XMLSchema#string

Eric T. Elwood

http://www.w3.org/2001/XMLSchema#string

Hong Rae Cho

http://www.w3.org/2001/XMLSchema#string

Kevin J. Winn

http://www.w3.org/2001/XMLSchema#string

Peter S. Linsley

http://www.w3.org/2001/XMLSchema#string

Rose Hendrix

http://www.w3.org/2001/XMLSchema#string

P2888

P304

434-438

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/381434A0

http://www.w3.org/2001/XMLSchema#string

P407

P433

6581

http://www.w3.org/2001/XMLSchema#string

P478

381

http://www.w3.org/2001/XMLSchema#string

P577

1996-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1027764557

http://www.w3.org/2001/XMLSchema#string